ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01586195
Brief Title: Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E

First Submitted : April 24, 2012
First Submitted that Met QC Criteria : April 24, 2012
First Posted : April 26, 2012 (Estimate)

Results First Submitted : July 7, 2016
Results First Submitted that Met QC Criteria : April 24, 2017
Results First Posted : May 25, 2017

Last Update Submitted that Met QC Criteria : April 24, 2017
Last Update Posted : May 25, 2017